David Geffen School of Medicine at UCLA-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2013

  1. Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

    The Lancet, Vol. 381, Núm. 9868, pp. 735-743